Activist Investing Nominates Slate of Highly Qualified Director Candidates for Election to the Board of Directors of Titan Pharmaceuticals at Upcoming Special Meeting of Stockholders
July 11, 2022 08:00 ET | Activist Investing LLC
NEW YORK, July 11, 2022 (GLOBE NEWSWIRE) -- David E. Lazar, Chief Executive Officer of Activist Investing LLC (together with its affiliates, “Activist Investing” or “we”), one of the largest...
Activist Investing Discloses 9.9% Ownership Interest in Titan Pharmaceuticals, Inc.
June 10, 2022 08:00 ET | Activist Investing LLC
NEW YORK, June 10, 2022 (GLOBE NEWSWIRE) -- David E. Lazar, Chief Executive Officer of Activist Investing LLC (together with its affiliates, “Activist Investing” or “we”), one of the largest...
Activist Investing Announces 5.6% Ownership Interest in Titan Pharmaceuticals, Inc.
April 25, 2022 13:29 ET | Activist Investing LLC
NEW YORK, April 25, 2022 (GLOBE NEWSWIRE) -- Activist Investing LLC (together with its affiliates, “Activist Investing” or “we”), today filed a Schedule 13D announcing its acquisition of...